Says continues to invest in R&D at “competitive levels.” Says “pleased” with free cash flow generation in Q1. Says capital allocation strategy remains unchanged. Says many catalysts in pipeline to drive growth. Comments taken from Q1 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- JNJ Earnings: Johnson & Johnson’s Q1 Earnings Beat Estimates
- Options Volatility and Implied Earnings Moves Today, April 16, 2024
- Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024
- Mind Medicine initiated with an Outperform at Leerink
- Integer upgraded to Buy from Neutral at BofA
